Jaguar Health, Inc. current report, 13 May 2019

Jaguar Health, Inc. (JAGX) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Jaguar Health, Inc. on May 13, 2019. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in San Francisco, California. Its common stock trades on The NASDAQ Capital Market under the symbol "JAGX".

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.

Material Changes and Events

On May 13, 2019, the Company received written notice from the Nasdaq Staff indicating a determination to delist its securities. This action follows the Company's continued non-compliance with the minimum $1.00 bid price requirement (Nasdaq Listing Rule 5550(a)(2)) as of May 8, 2019. Although the Company satisfied the quantitative criteria for a second 180-day grace period, the Nasdaq Staff exercised its discretion to deny this extension.

Outlook, Management Commentary, and Risks

  • Management Action: The Company intends to timely request a hearing before the Nasdaq Hearings Panel to seek an extension to evidence compliance with listing requirements.
  • Procedural Status: The request for a hearing will stay any suspension or delisting action pending the outcome of the hearing.
  • Risks and Uncertainties: There is no assurance that the Panel will grant the request for continued listing or that the Company will be able to evidence compliance within any granted extension period. The Company plans to take definitive steps to cure the deficiency, potentially including a reverse stock split.

Key Facts for Investor Verification

  • Verify the current status of the Company's request for a hearing before the Nasdaq Hearings Panel.
  • Monitor the Company's stock bid price to determine if it has returned to or above the $1.00 threshold.
  • Check for subsequent filings regarding the outcome of the hearing or any announced reverse stock split.
  • Confirm whether the Company has been officially delisted from The NASDAQ Capital Market.